CHRS - Coherus Biosciences Inc
IEX Last Trade
1.39
-0.030 -2.158%
Share volume: 593,447
Last Updated: Fri 30 Aug 2024 09:57:45 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.42
-0.03
-2.11%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-08 | 2023-03-06 | 2023-05-08 | 2023-08-02 | 2023-11-06 | 2024-03-15 | 2024-05-09 | |
| Total revenue | 60.151 M | 45.424 M | 45.352 M | 32.436 M | 58.716 M | 74.568 M | 91.524 M | 77.063 M | |
| Cost of revenue | 11.277 M | 35.234 M | 14.202 M | 16.874 M | 24.848 M | 32.703 M | 84.567 M | 34.586 M | |
| Gross profit | 48.874 M | 10.190 M | 31.150 M | 15.562 M | 33.868 M | 41.865 M | 6.957 M | 42.477 M | |
| -79.15% | 205.69% | -50.04% | 117.63% | 23.61% | -83.38% | 510.56% | |||
| Operating expenses | 92.887 M | 90.639 M | 82.643 M | 83.307 M | 68.411 M | 73.871 M | 75.862 M | 85.002 M | |
| Selling general and admin | 51.276 M | 44.831 M | 53.621 M | 49.153 M | 45.144 M | 48.224 M | 49.494 M | 56.532 M | |
| Research and development | 41.611 M | 45.808 M | 29.022 M | 34.154 M | 23.267 M | 25.647 M | 26.368 M | 28.470 M | |
| Total expenses | 104.164 M | 125.873 M | 96.845 M | 100.181 M | 93.259 M | 106.574 M | 160.429 M | 119.588 M | |
| 20.84% | -23.06% | 3.44% | -6.91% | 14.28% | 50.53% | -25.46% | |||
| Operating income | -44.013 M | -80.449 M | -51.493 M | -67.745 M | -34.543 M | -32.006 M | -68.905 M | -42.525 M | |
| Ebit | -44.013 M | -80.449 M | -51.493 M | -67.745 M | -34.543 M | -32.006 M | -68.905 M | -42.525 M | |
| Pretax income | -50.150 M | -86.650 M | -58.870 M | -75.729 M | -42.869 M | -40.021 M | -79.653 M | 102.875 M | |
| 72.78% | -32.06% | 28.64% | -43.39% | -6.64% | 99.03% | -229.15% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -380.000 K | 0.000 | 0.000 | |
| Net income basic | -50.150 M | -86.650 M | -58.870 M | -75.729 M | -42.869 M | -39.641 M | -79.653 M | 102.875 M | |
| -72.78% | 32.06% | -28.64% | 43.39% | 7.53% | -100.94% | 229.15% | |||
| Net income | -50.150 M | -86.650 M | -58.870 M | -75.729 M | -42.869 M | -39.641 M | -79.653 M | 102.875 M | |
| -72.78% | 32.06% | -28.64% | 43.39% | 7.53% | -100.94% | 229.15% |